Literature DB >> 19026658

Severe myopathy mutations modify the nanomechanics of desmin intermediate filaments.

L Kreplak1, H Bär.   

Abstract

Mutations in the intermediate filament (IF) protein desmin cause severe forms of myofibrillar myopathy characterized by partial aggregation of the extrasarcomeric desmin cytoskeleton and structural disorganization of myofibrils. In contrast to prior expectations, we showed that some of the known disease-causing mutations, such as DesA360P, DesQ389P and DesD399Y, are assembly-competent and do allow formation of bona fide IFs in vitro and in vivo. We also previously demonstrated that atomic force microscopy can be employed to measure the tensile properties of single desmin IFs. Using the same approach on filaments formed by the aforementioned mutant desmins, we now observed two different nanomechanical behaviors: DesA360P exhibited tensile properties similar to that of wild-type desmin IFs, whereas DesQ389P and DesD399Y exhibited local variations in their tensile properties along the filament length. Based on these findings, we hypothesize that DesQ389P and DesD399Y may cause muscle disease by altering the specific biophysical properties of the desmin filaments, thereby compromising both its mechanosensing and mechanotransduction ability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19026658     DOI: 10.1016/j.jmb.2008.10.095

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  17 in total

Review 1.  Intermediate Filaments Play a Pivotal Role in Regulating Cell Architecture and Function.

Authors:  Jason Lowery; Edward R Kuczmarski; Harald Herrmann; Robert D Goldman
Journal:  J Biol Chem       Date:  2015-05-08       Impact factor: 5.157

2.  Disease mutations in the "head" domain of the extra-sarcomeric protein desmin distinctly alter its assembly and network-forming properties.

Authors:  Sarika Sharma; Norbert Mücke; Hugo A Katus; Harald Herrmann; Harald Bär
Journal:  J Mol Med (Berl)       Date:  2009-09-08       Impact factor: 4.599

Review 3.  Mechanotransduction in cardiac hypertrophy and failure.

Authors:  Robert C Lyon; Fabian Zanella; Jeffrey H Omens; Farah Sheikh
Journal:  Circ Res       Date:  2015-04-10       Impact factor: 17.367

Review 4.  Molecular insights into cardiomyopathies associated with desmin (DES) mutations.

Authors:  Andreas Brodehl; Anna Gaertner-Rommel; Hendrik Milting
Journal:  Biophys Rev       Date:  2018-06-20

5.  Desmin Mutation in the C-Terminal Domain Impairs Traction Force Generation in Myoblasts.

Authors:  Elisabeth E Charrier; Atef Asnacios; Rachel Milloud; Richard De Mets; Martial Balland; Florence Delort; Olivier Cardoso; Patrick Vicart; Sabrina Batonnet-Pichon; Sylvie Hénon
Journal:  Biophys J       Date:  2016-01-19       Impact factor: 4.033

6.  Mutation in the Core Structure of Desmin Intermediate Filaments Affects Myoblast Elasticity.

Authors:  Catherine Even; Gilles Abramovici; Florence Delort; Anna F Rigato; Virginie Bailleux; Abel de Sousa Moreira; Patrick Vicart; Felix Rico; Sabrina Batonnet-Pichon; Fatma Briki
Journal:  Biophys J       Date:  2017-08-08       Impact factor: 4.033

7.  Diagnostic challenge in desmin cardiomyopathy with transformation of clinical phenotypes.

Authors:  Alexandra Gudkova; Anna Kostareva; Gunnar Sjoberg; Natalia Smolina; Marinan Turalchuk; Irina Kuznetsova; Margarita Rybakova; Lars Edstrom; Eugene Shlyakhto; Thomas Sejersen
Journal:  Pediatr Cardiol       Date:  2012-04-07       Impact factor: 1.655

Review 8.  Desminopathies: pathology and mechanisms.

Authors:  Christoph S Clemen; Harald Herrmann; Sergei V Strelkov; Rolf Schröder
Journal:  Acta Neuropathol       Date:  2012-11-11       Impact factor: 17.088

9.  Desmin A213V substitution represents a rare polymorphism but not a mutation and is more prevalent in patients with heart dilation of various origins.

Authors:  A Kostareva; G Sjoberg; A Gudkova; N Smolina; E Semernin; E Shlyakhto; T Sejersen
Journal:  Acta Myol       Date:  2011-06

10.  Hierarchical structure controls nanomechanical properties of vimentin intermediate filaments.

Authors:  Zhao Qin; Laurent Kreplak; Markus J Buehler
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.